Bis(4-nitrophenyl) carbonate (CAS 5070-13-3, NPC; also called 4-nitrophenyl carbonate or di(4-nitrophenyl) carbonate) is a crystalline activated carbonate reagent, C13H8N2O7 with a relative molecular mass near 304 and a melting range around 137-142 C. It occupies a specific niche in fine-chemical and CDMO work: a stable, weighable solid that delivers carbonyl groups to amines and alcohols under mild conditions, giving carbamates, ureas and carbonates while releasing p-nitrophenol as a spectroscopically visible leaving group. That combination is why it is specified in peptide and linker chemistry, carbamate prodrug research, dendrimer and polycarbonate work, and in laboratory programmes that need a carbonylating reagent without handling phosgene at the bench.
Commercial value in this category is determined less by nominal assay than by the impurity and handling profile that sits behind it: residual p-nitrophenol, residual chlorinated solvent, residual phosgene or triphosgene-derived species, moisture content and thermal-stability behaviour. Production route classes are phosgene- or triphosgene-based carbonylation of p-nitrophenol, with diphenyl carbonate transesterification as an alternative that avoids phosgene entirely; each carries a different plant-capability requirement, and phosgene capability in particular is a genuine barrier to entry rather than a marketing claim. This paper treats route chemistry only at that capability level, without procedural detail.
The following sections examine the leaving-group chemistry, plant capability and by-product management, specification and analytical strategy including ICH M7 reasoning for nitrophenol and chloroformate residues, the European and North American regulatory perimeter covering REACH, CLP, TSCA and GHS, dry inert packaging and transport practice, and the choice between research-use and GMP campaign supply. Section IX maps the China, India and European Union ecosystems that dominate supply.
NPC is a symmetric diaryl carbonate in which both phenoxy groups are para-nitrated. The nitro group withdraws electron density and stabilises the phenoxide anion, which makes p-nitrophenol an excellent leaving group and therefore makes the carbonyl carbon strongly electrophilic relative to ordinary diaryl carbonates. In practice an amine attacks the carbonyl, p-nitrophenoxide departs to give a reactive 4-nitrophenyl carbamate intermediate, and a second nucleophile displaces the second nitrophenoxide to form the urea or carbamate product. The practical consequence for process chemists is that the reaction is self-indicating: liberated p-nitrophenol and its anion are intensely coloured and readily quantified, so conversion can be followed without exotic analytics.
Two route classes supply commercial NPC: carbonylation of p-nitrophenol with phosgene or with the solid phosgene equivalent triphosgene under basic conditions, and phosgene-free transesterification from diphenyl carbonate. Which a producer can run is a plant-capability question: phosgene routes require a contained phosgene operation with dedicated generation or supply, scrubbing, detection and emergency systems, whereas diphenyl carbonate routes trade that hazard for a higher thermal duty and more demanding equilibrium management.
Demand tracks pharmaceutical and materials R&D rather than a single end market. Growth comes from carbamate and linker chemistry in small-molecule development, from peptide and oligonucleotide conjugate work, and from polymer and coating programmes seeking controlled carbonate incorporation. The structural shift worth noting in 2026 is specification-driven: buyers moving from research into development stop accepting catalogue-grade material and start demanding justified impurity limits, residual-solvent data and stability evidence, which converts a spot purchase into a qualified-supplier relationship.
Capacity concentrates where two capabilities coexist: aryl nitro chemistry and, for the dominant route, licensed phosgene or triphosgene handling. China and India host most of the cost-competitive capacity and a growing share of documented GMP-supporting material, while European producers and toll manufacturers retain strength in contained phosgene operations and in high-documentation campaigns. Export flows are predominantly small-lot and air-freighted for research grades, with larger campaign volumes moving by sea in temperature-controlled or at least moisture-protected packaging.
The market has bifurcated into catalogue research grade, where price competition is intense and specifications are thin, and development or GMP-supporting grade, where premiums attach to impurity justification, validated methods, stability data and a documented change-control history. Discounts in the lower tier usually signal unstated p-nitrophenol, unqualified residual-solvent limits or moisture-protection shortcuts, all of which reappear as yield loss or failed impurity specifications in the customer's own process.
NPC sits at the intersection of chemical inventory regulation and pharmaceutical quality expectations. As an industrial reagent the operative instruments are REACH, CLP and TSCA plus GHS labelling and transport rules; as an input to a regulated API the same lot is pulled into ICH Q7 supplier qualification, Q11 development reporting, Q3C residual-solvent limits and M7 impurity assessment. Suppliers who can serve both worlds with one document package win the development-grade business.
The environmental profile of NPC manufacture is dominated by phenolic and chlorinated waste streams rather than by energy, and ESG scrutiny therefore focuses on nitrophenol recovery, solvent management and the controls around any phosgene operation.
Credible reduction measures are process-integrated: recovery and recycle of p-nitrophenol into the carbonylation step, chlorinated-solvent recovery by distillation rather than disposal, heat integration around the exothermic carbonylation, and phosgene-on-demand generation that minimises inventory. Scope 1 reporting should cover abatement and scrubbing, and Scope 3 should cover solvent and phenol transport and disposal, since those streams dominate the cradle-to-gate picture at this production scale.
Traceability expectations centre on the phenolic and solvent inputs: origin and specification of p-nitrophenol, identity and grade of chlorinated solvent, and documented accountability for any phosgene used. Where a customer's own ESG reporting requires supplier data, producers with ISO 9001 or ISO 14001 systems and retained-sample discipline can respond from records rather than from estimates, which increasingly decides tender outcomes in the development-grade tier.
NPC is not a temperature-sensitive biological, but it is moisture-sensitive in a way that is easy to underestimate: a sealed drum that sweats through a humid sea voyage can arrive with measurable hydrolysis. Logistics specification should therefore be built around dryness and inertness rather than refrigeration.
Pure NPC is generally not assigned a UN dangerous-goods classification when supplied within specification, although classification must always be confirmed against the actual impurity profile and the current regulations; where residual solvent or nitrophenol content drives hazard, the consignment may require environmental-hazard or irritant classification and the corresponding packaging and labelling. Air freight is standard for research quantities, while campaign volumes move by sea with desiccant and moisture-barrier protection and, for sensitive lanes, temperature-and-humidity data logging. Documentation should carry the CAS number, the GHS labelling set and any residual-solvent statement that affects classification.
Buyers who progress from research into development should make three moves early, because each is cheaper before a validated process is locked around a supplier's material.
Bis(4-nitrophenyl) carbonate is a mature reagent whose commercial risk lies in specification detail rather than in chemistry. Its value comes from the p-nitrophenol leaving group, and its problems come from the same place: residual nitrophenol, moisture-driven hydrolysis and reactive phosgene-derived residues are what differentiate a reagent that behaves predictably in a validated step from one that quietly changes stoichiometry. Buyers who specify and test those attributes convert a commodity purchase into a controlled input.
Through 2026 the market will continue to split between catalogue supply and development-grade supply, and the dividing line is documentation: ICH Q7 qualification, Q11 reporting, Q3C solvent control and M7 impurity justification, supported by dry inert packaging and honest stability data. Producers able to combine contained carbonylation capability with nitrophenol recovery and a validated analytical package will capture the campaign business, while undifferentiated research-grade supply will remain a price-driven, low-margin activity.
Powered by Guidechem
This white paper is exclusively compiled by the Guidechem Intelligence Team based on global customs data, regulatory databases, and industry research. Guidechem is a leading global B2B chemical platform, dedicated to connecting global buyers with verified, high-quality manufacturers.
Relying on Guidechem's extensive global database, we have mapped the core participants in the current global Bis(4-nitrophenyl) carbonate supply chain:
Disclaimer: The content of this white paper is compiled based on public market data and regulatory information available as of 2026. Global chemical regulations are subject to dynamic adjustments. In actual export operations, enterprises must consult professional regulatory advisors or relevant competent authorities to obtain the latest compliance guidance.
![]() |